DEBN Competitors and Similar CompaniesClear all
DEBN's competitors and similar companies include Nucleix and Precipio.
 Nucleix Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. |  Precipio Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market. | ||
Founding Date | Founding Date 2017 | Founding Date 2008 | Founding Date 1997 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Gdańsk, PL HQ Renens, CH | Locations Rehovot, IL HQ San Diego, US | Locations Omaha, US HQ Glasgow, GB New Haven, US Omaha, US |
Employees | Employees 3 | Employees 72 | Employees 4235% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 61m | Total funding raised $ 1.5m |
For sources of this data, please see the company profile
View Company Profiles
Nucleix
HQ
Rehovot, IL
Employees
72
Nucleix is a company that develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.
View companyPrecipio
HQ
Omaha, US
Employees
42↑ 35% increase
Precipio (formerly Transgenomic) is a company operating as a cancer diagnostics reference laboratory providing products and services to the oncology market.
View company